|
|
Volumn 8, Issue 22, 2002, Pages 1945-1958
|
|
Inhibition of NF-κB and proteasome activity in tumors: Can we improve the therapeutic potential of topoisomerase I and topoisomerase II poisons
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
ANTINEOPLASTIC AGENT;
BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL;
BORTEZOMIB;
CAMPTOTHECIN DERIVATIVE;
CISPLATIN;
CYTOTOXIC AGENT;
DAUNORUBICIN;
DNA;
DNA TOPOISOMERASE;
DNA TOPOISOMERASE (ATP HYDROLYSING);
DOXORUBICIN;
DRUG METABOLITE;
ENZYME INHIBITOR;
ETOPOSIDE;
IRINOTECAN;
MITOMYCIN C;
PACLITAXEL;
PROTEASOME;
PROTEASOME INHIBITOR;
PS 431;
SURVIVIN;
SYNAPTOTAGMIN;
TENIPOSIDE;
TOPOTECAN;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR NF KAPPAB;
TRANSCRIPTION FACTOR REL;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VINBLASTINE;
CYSTEINE PROTEINASE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
MULTIENZYME COMPLEX;
APOPTOSIS;
CANCER MODEL;
CELL DEATH;
CONTROLLED STUDY;
DNA DAMAGE;
DRUG MECHANISM;
DRUG POTENCY;
DRUG POTENTIATION;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
ENZYME INACTIVATION;
ENZYME INHIBITION;
ENZYME REGULATION;
GENETIC TRANSFECTION;
HUMAN;
HUMAN TISSUE;
LUNG NON SMALL CELL CANCER;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
REVIEW;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ANIMAL;
DRUG ANTAGONISM;
LUNG TUMOR;
PATHOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CARCINOMA, NON-SMALL-CELL LUNG;
CYSTEINE ENDOPEPTIDASES;
DNA DAMAGE;
DNA TOPOISOMERASES, TYPE I;
DNA TOPOISOMERASES, TYPE II;
HUMANS;
LUNG NEOPLASMS;
MULTIENZYME COMPLEXES;
NF-KAPPA B;
PROTEASOME ENDOPEPTIDASE COMPLEX;
|
|
EID: 0036025366
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/1381612023393549 Document Type: Review |
|
Times cited : (14)
|
|
References (72)
|
